Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00489957 · ClinicalTrials.gov registry record
Speckle Tracking in Pediatric Patients
A clinical trial of Cardiomyopathy, sponsored by Emory University.
- Completed
- Registry status
- 70
- Enrollment target
- 1
- Study location
NCT00489957 is a study of Cardiomyopathy that has completed, run by Emory University. The registered enrollment target is 70 participants, below the 554-participant average among 25 other Cardiomyopathy trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00489957, a study of Cardiomyopathy, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
An echocardiogram, also called a cardiac ultrasound or echo, is a medical test that takes pictures of the heart using sound waves. It shows images of the structures of the heart without using radiation. During the last year, the FDA has approved a new technology called Speckle Tracking that can look at the heart wall motion and contraction (pumping or squeezing) abnormalities. The study will also employ tissue Doppler and 3-Dimensional echo and uses the same echocardiographic machines which are used right now. The machines are upgraded with the new software application. This new technology is currently being used in adults, but unfortunately, there is almost no published data about normal heart function in infants and children using this technology. It is known from other technologies that the developing child's heart is not the same as an adult. The investigators wish to study this new technology and compare it to other technologies currently being used.
Conditions Studied
Study Locations (1)
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00489957
The ClinicalTrials.gov registry entry for NCT00489957 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 554-participant average among 25 other Cardiomyopathy trials with a reported enrollment target (87% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cardiomyopathy appearing as the primary indexed condition, and to 0 interventions.
NCT00489957 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT00489957 about?
NCT00489957 is a clinical study titled "Speckle Tracking in Pediatric Patients". An echocardiogram, also called a cardiac ultrasound or echo, is a medical test that takes pictures of the heart using sound waves. It shows images of the structures of the heart without using radiation. During the last year, the FDA has approved a new technology called Speckle Tracking that can look...
What is the current status of trial NCT00489957?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2007-03. Estimated completion is 2009-12.
What conditions does trial NCT00489957 study?
This clinical trial studies the following conditions: Cardiomyopathy.
Who is sponsoring clinical trial NCT00489957?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00489957 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiomyopathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
RECRUITING
-
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
RECRUITING · Phase 4
-
Molecular Imaging of Primary Amyloid Cardiomyopathy
RECRUITING · NA
-
Impella Reverse Remodeling in End-Stage Heart Failure
RECRUITING
-
Clinical Course Of Disease In Participants With FA-CM
RECRUITING
-
Genetics of Cardiovascular and Neuromuscular Disease
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.